Facetten
Zugriff
Einrichtung
Medientyp
- Text 5
Karte
Erscheinungsjahr
Autor/in
- Ettl, Johannes 5
- Fasching, Peter A 5
- Hadji, Peyman 5
- Hartkopf, Andreas D 5
- Häberle, Lothar
- alle zeigen
Sprache
- Englisch 5
5 Einträge gefunden
-
Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT
- Engler, Tobias
- Fasching, Peter A
- Lüftner, Diana
- Hartkopf, Andreas D
- Müller, Volkmar
- Kolberg, Hans-Christian
- Hadji, Peyman
-
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry
- Müller, Volkmar
- Hein, Alexander
- Hartkopf, Andreas D
- Fasching, Peter A
- Kolberg, Hans-Christian
- Hadji, Peyman
- Tesch, Hans
-
Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"
- Schneeweiss, Andreas
- Ettl, Johannes
- Lüftner, Diana
- Beckmann, Matthias W
- Belleville, Erik
- Fasching, Peter A
- Fehm, Tanja N
-
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany
- Schneeweiss, Andreas
- Ettl, Johannes
- Lüftner, Diana
- Beckmann, Matthias W
- Belleville, Erik
- Fasching, Peter A
- Fehm, Tanja N
-
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
- Michel, Laura L
- Hartkopf, Andreas D
- Fasching, Peter A
- Kolberg, Hans-Christian
- Hadji, Peyman
- Tesch, Hans
- Häberle, Lothar